HEADER HYDROLASE 08-AUG-04 1WNQ OBSLTE 20-SEP-05 1WNQ 2D2D TITLE CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN TITLE 2 INHIBITOR I2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.24.-; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS; SOURCE 3 ORGANISM_COMMON: VIRUSES; SOURCE 4 STRAIN: BJ01; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BACTERIA; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS ANTI-PARALLEL B-BARREL, ANTI-PARALLEL A-HELICES EXPDTA X-RAY DIFFRACTION AUTHOR H.YANG,M.BARTLAM,X.XUE,K.YANG,W.LIANG,Y.DING,Z.RAO REVDAT 2 20-SEP-05 1WNQ 1 OBSLTE REVDAT 1 30-AUG-05 1WNQ 0 JRNL AUTH H.YANG,M.BARTLAM,X.XUE,K.YANG,W.LIANG,Y.DING,Z.RAO JRNL TITL DESIGN OF WIDE-SPECTRUM INHIBITORS TARGETING JRNL TITL 2 CORONAVIRUS MAIN PROTEASES JRNL REF PLOS BIOL. 2005 JRNL REFN US ESSN 1545-7885 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 15970 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 785 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4669 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 136 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.52 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1WNQ COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-AUG-2004. REMARK 100 THE RCSB ID CODE IS RCSB023788. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-DEC-2003 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16799 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, MES, DMSO, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.36850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 GLY B -4 REMARK 465 PRO B -3 REMARK 465 LEU B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 PHE B 305 REMARK 465 GLN B 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 SG CYS A 145 C2 ENB 145 1.84 REMARK 500 SG CYS B 145 C2 ENB 1145 1.84 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 145 N CYS A 145 CA -0.265 REMARK 500 CYS A 145 C CYS A 145 O -0.130 REMARK 500 SER A 144 C CYS A 145 N -0.104 REMARK 500 CYS A 145 C GLY A 146 N 0.325 REMARK 500 CYS B 145 CA CYS B 145 C -0.123 REMARK 500 CYS B 145 C CYS B 145 O 0.206 REMARK 500 CYS B 145 C GLY B 146 N 0.075 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 70 N - CA - C ANGL. DEV. = -9.5 DEGREES REMARK 500 ARG A 88 N - CA - C ANGL. DEV. =-10.2 DEGREES REMARK 500 LYS A 100 N - CA - C ANGL. DEV. =-11.0 DEGREES REMARK 500 PHE A 103 N - CA - C ANGL. DEV. =-11.0 DEGREES REMARK 500 CYS A 145 CB - CA - C ANGL. DEV. =-13.8 DEGREES REMARK 500 CYS A 145 N - CA - CB ANGL. DEV. = 14.8 DEGREES REMARK 500 CYS A 145 CA - C - O ANGL. DEV. = 13.5 DEGREES REMARK 500 CYS A 145 O - C - N ANGL. DEV. =-15.0 DEGREES REMARK 500 ASP A 176 N - CA - C ANGL. DEV. = -9.6 DEGREES REMARK 500 TYR A 182 N - CA - C ANGL. DEV. = -9.8 DEGREES REMARK 500 LYS B 5 N - CA - C ANGL. DEV. =-11.5 DEGREES REMARK 500 CYS B 22 N - CA - C ANGL. DEV. = -9.3 DEGREES REMARK 500 LEU B 87 N - CA - C ANGL. DEV. =-10.1 DEGREES REMARK 500 LYS B 100 N - CA - C ANGL. DEV. =-12.1 DEGREES REMARK 500 CYS B 145 CB - CA - C ANGL. DEV. =-14.5 DEGREES REMARK 500 SER B 144 CA - C - N ANGL. DEV. =-12.0 DEGREES REMARK 500 CYS B 145 C - N - CA ANGL. DEV. =-19.8 DEGREES REMARK 500 CYS B 145 O - C - N ANGL. DEV. = -9.4 DEGREES REMARK 500 TYR B 182 N - CA - C ANGL. DEV. =-14.2 DEGREES REMARK 500 GLY B 195 N - CA - C ANGL. DEV. = 9.5 DEGREES REMARK 500 GLN B 256 N - CA - C ANGL. DEV. = -9.3 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 84 -110.84 62.38 REMARK 500 TYR A 154 -100.96 67.48 REMARK 500 TYR B 154 -78.96 77.34 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UJ1 RELATED DB: PDB REMARK 900 RELATED ID: 1WNP RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH AN 11-MER PEPTIDE SUBSTRATE REMARK 900 RELATED ID: 1WOF RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH AN INHIBITOR N1 DBREF 1WNQ A 1 306 UNP P59641 R1AB_CVHSA 3241 3546 DBREF 1WNQ B 1 306 UNP P59641 R1AB_CVHSA 3241 3546 SEQADV 1WNQ GLY A -4 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ PRO A -3 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ LEU A -2 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ GLY A -1 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ SER A 0 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ GLY B -4 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ PRO B -3 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ LEU B -2 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ GLY B -1 UNP P59641 CLONING ARTIFACT SEQADV 1WNQ SER B 0 UNP P59641 CLONING ARTIFACT SEQRES 1 A 311 GLY PRO LEU GLY SER SER GLY PHE ARG LYS MET ALA PHE SEQRES 2 A 311 PRO SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR SEQRES 3 A 311 CYS GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP SEQRES 4 A 311 THR VAL TYR CYS PRO ARG HIS VAL ILE CYS THR ALA GLU SEQRES 5 A 311 ASP MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG SEQRES 6 A 311 LYS SER ASN HIS SER PHE LEU VAL GLN ALA GLY ASN VAL SEQRES 7 A 311 GLN LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS LEU SEQRES 8 A 311 LEU ARG LEU LYS VAL ASP THR SER ASN PRO LYS THR PRO SEQRES 9 A 311 LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SEQRES 10 A 311 SER VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL SEQRES 11 A 311 TYR GLN CYS ALA MET ARG PRO ASN HIS THR ILE LYS GLY SEQRES 12 A 311 SER PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN SEQRES 13 A 311 ILE ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS SEQRES 14 A 311 MET GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU SEQRES 15 A 311 GLU GLY LYS PHE TYR GLY PRO PHE VAL ASP ARG GLN THR SEQRES 16 A 311 ALA GLN ALA ALA GLY THR ASP THR THR ILE THR LEU ASN SEQRES 17 A 311 VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP SEQRES 18 A 311 ARG TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP SEQRES 19 A 311 PHE ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU SEQRES 20 A 311 THR GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA SEQRES 21 A 311 GLN THR GLY ILE ALA VAL LEU ASP MET CYS ALA ALA LEU SEQRES 22 A 311 LYS GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE SEQRES 23 A 311 LEU GLY SER THR ILE LEU GLU ASP GLU PHE THR PRO PHE SEQRES 24 A 311 ASP VAL VAL ARG GLN CYS SER GLY VAL THR PHE GLN SEQRES 1 B 311 GLY PRO LEU GLY SER SER GLY PHE ARG LYS MET ALA PHE SEQRES 2 B 311 PRO SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR SEQRES 3 B 311 CYS GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP SEQRES 4 B 311 THR VAL TYR CYS PRO ARG HIS VAL ILE CYS THR ALA GLU SEQRES 5 B 311 ASP MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG SEQRES 6 B 311 LYS SER ASN HIS SER PHE LEU VAL GLN ALA GLY ASN VAL SEQRES 7 B 311 GLN LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS LEU SEQRES 8 B 311 LEU ARG LEU LYS VAL ASP THR SER ASN PRO LYS THR PRO SEQRES 9 B 311 LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SEQRES 10 B 311 SER VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL SEQRES 11 B 311 TYR GLN CYS ALA MET ARG PRO ASN HIS THR ILE LYS GLY SEQRES 12 B 311 SER PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN SEQRES 13 B 311 ILE ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS SEQRES 14 B 311 MET GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU SEQRES 15 B 311 GLU GLY LYS PHE TYR GLY PRO PHE VAL ASP ARG GLN THR SEQRES 16 B 311 ALA GLN ALA ALA GLY THR ASP THR THR ILE THR LEU ASN SEQRES 17 B 311 VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP SEQRES 18 B 311 ARG TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP SEQRES 19 B 311 PHE ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU SEQRES 20 B 311 THR GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA SEQRES 21 B 311 GLN THR GLY ILE ALA VAL LEU ASP MET CYS ALA ALA LEU SEQRES 22 B 311 LYS GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE SEQRES 23 B 311 LEU GLY SER THR ILE LEU GLU ASP GLU PHE THR PRO PHE SEQRES 24 B 311 ASP VAL VAL ARG GLN CYS SER GLY VAL THR PHE GLN HET ENB 145 40 HET ENB 1145 40 HETNAM ENB ETHYL (2E,4S)-4-[((2R)-2-{[N-(TERT-BUTOXYCARBONYL)-L- HETNAM 2 ENB VALYL]AMINO}-2-PHENYLETHANOYL)AMINO]-5-[(3S)-2- HETNAM 3 ENB OXOPYRROLIDIN-3-YL]PENT-2-ENOATE HETSYN ENB (E)-(S)-4-[(S)-2-((S)-2-TERT-BUTOXYCARBONYLAMINO-3- HETSYN 2 ENB METHYL-BUTYRYLAMINO)-2-PHENYL-ACETYLAMINO]-5-(2-OXO- HETSYN 3 ENB PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER FORMUL 3 ENB 2(C29 H42 N4 O7) FORMUL 5 HOH *136(H2 O1) HELIX 1 1 SER A 10 GLY A 15 1 6 HELIX 2 2 HIS A 41 CYS A 44 5 4 HELIX 3 3 ASN A 53 ARG A 60 1 8 HELIX 4 4 SER A 62 HIS A 64 5 3 HELIX 5 5 ILE A 200 GLY A 215 1 16 HELIX 6 6 THR A 226 TYR A 237 1 12 HELIX 7 7 THR A 243 GLY A 258 1 16 HELIX 8 8 ALA A 260 ASN A 274 1 15 HELIX 9 9 THR A 292 SER A 301 1 10 HELIX 10 10 SER B 10 GLY B 15 1 6 HELIX 11 11 HIS B 41 ILE B 43 5 3 HELIX 12 12 ALA B 46 LEU B 50 5 5 HELIX 13 13 ASN B 53 ARG B 60 1 8 HELIX 14 14 SER B 62 HIS B 64 5 3 HELIX 15 15 ILE B 200 ASN B 214 1 15 HELIX 16 16 THR B 226 MET B 235 1 10 HELIX 17 17 LYS B 236 ASN B 238 5 3 HELIX 18 18 THR B 243 LEU B 250 1 8 HELIX 19 19 LEU B 250 GLN B 256 1 7 HELIX 20 20 THR B 257 ILE B 259 5 3 HELIX 21 21 ALA B 260 GLY B 275 1 16 HELIX 22 22 THR B 292 SER B 301 1 10 SHEET 1 A 7 VAL A 73 LEU A 75 0 SHEET 2 A 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 A 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 A 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 A 7 THR A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 A 7 LEU A 86 LYS A 90 -1 O LEU A 87 N CYS A 38 SHEET 7 A 7 SER A 81 GLN A 83 -1 N SER A 81 O ARG A 88 SHEET 1 B 5 TYR A 101 PHE A 103 0 SHEET 2 B 5 CYS A 156 MET A 165 1 O VAL A 157 N LYS A 102 SHEET 3 B 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 B 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 B 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 C 3 TYR A 101 PHE A 103 0 SHEET 2 C 3 CYS A 156 MET A 165 1 O VAL A 157 N LYS A 102 SHEET 3 C 3 ALA A 173 THR A 175 -1 O THR A 175 N MET A 162 SHEET 1 D 6 VAL B 73 GLN B 74 0 SHEET 2 D 6 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 D 6 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 D 6 THR B 25 PRO B 39 -1 O THR B 25 N CYS B 22 SHEET 5 D 6 LEU B 86 ASN B 95 -1 O LEU B 89 N VAL B 36 SHEET 6 D 6 VAL B 77 GLY B 79 -1 N GLY B 79 O LYS B 90 SHEET 1 E 6 VAL B 73 GLN B 74 0 SHEET 2 E 6 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 E 6 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 E 6 THR B 25 PRO B 39 -1 O THR B 25 N CYS B 22 SHEET 5 E 6 LEU B 86 ASN B 95 -1 O LEU B 89 N VAL B 36 SHEET 6 E 6 MET B 82 GLN B 83 -1 N GLN B 83 O LEU B 86 SHEET 1 F 5 LYS B 100 PHE B 103 0 SHEET 2 F 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 F 5 VAL B 148 ASP B 153 -1 N GLY B 149 O TYR B 161 SHEET 4 F 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 F 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 G 3 LYS B 100 PHE B 103 0 SHEET 2 G 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 G 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 CRYST1 50.703 94.737 66.204 90.00 103.04 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019723 0.000000 0.004568 0.00000 SCALE2 0.000000 0.010556 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015505 0.00000